00:00 The strategic value is extremely high, because the F-Rex's spearhead product is the second product for us in terms of turnover,
00:09 within the skeletal muscle area of bone metabolism.
00:13 What does this allow us to do?
00:15 On the one hand, it allows us to secure the asset, because it allows us to have the availability of the product for Italy for the next few years.
00:24 At the same time, it allows us to have a product portfolio available for the international market,
00:30 which represents the correct and complete framework for osteoporosis therapy.
00:35 This is alien drone, which we have already mentioned, vitamin D and calcium.
00:41 The goal is to take advantage of the experience and skills that we have developed in Italy over the years
00:47 and to be able to replicate it also in the international field.
00:51 This is not only with a direct presence in Switzerland, in this case thanks to the acquisition of F-Rex,
00:58 but also in Germany, where we made our first acquisition last year, and also with all our current partners.
Comments